Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


  1. Published

    Clinically-suspected cast nephropathy: A retrospective, national, real-world study

    Szabo, A. G., Thorsen, Jonathan Jan Ilve, Iversen, K. F., Hansen, C. T., Teodorescu, E. M., Pedersen, S. B., Flaeng, S. B., Strandholdt, C., Frederiksen, M., Vase, M. Ø., Frølund, U. C., Krustrup, D., Plesner, T. & Vangsted, Annette Juul, 2020, In: American Journal of Hematology. 95, 11, p. 1352-1360 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio

    Szabo, A. G., Klausen, T. W., Abildgaard, N., Gregersen, H., Silkjær, T., Pedersen, P. T., Pedersen, R. S., Helleberg, C., Hermansen, E., Schnack, B. I. & Vangsted, Annette Juul, 2021, In: Blood Cancer Journal. 11, 4, 70.

    Research output: Contribution to journalLetterResearchpeer-review

  3. Published

    The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

    Szabo, A. G., Thorsen, J., Iversen, K. F., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C. N., Andersen, M. K. & Vangsted, Annette Juul, 2022, In: American Journal of Hematology. 97, 3, p. E117-E120

    Research output: Contribution to journalLetterResearchpeer-review

  4. Published

    The real-world outcomes of multiple myeloma patients treated with daratumumab

    Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Plos One. 16, 10 October, p. 1-11 e0258487.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul, Østergaard, B., Gregersen, H., Frølund, U. C., Andersen, N. F., Helleberg, C., Andersen, K. T., Pedersen, R. S., Pedersen, P., Abildgaard, N., Gimsing, P. & Danish Myeloma Study Group, D. M. S. G., Sep 2016, In: European Journal of Haematology. 97, 3, p. 303-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul & Gimsing, P., 2019, In: European Journal of Haematology. 102, 2, p. 182-190

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul & Gimsing, P., 2018, In: European Journal of Haematology. 101, 1, p. 21-27 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul, Frølund, U. C., Andersen, K. T., Klostergaard, A., Helleberg, C., Pedersen, R. S., Pedersen, P. T., Helm-Petersen, S., Teodorescu, E. M., Preiss, B., Abildgaard, N. & Gimsing, P., Dec 2017, In: PLoS ONE. 12, 12, 15 p., e0188988.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

    Terpos, E., Engelhardt, M., Cook, G., Gay, F., Mateos, M. V., Ntanasis-Stathopoulos, I., van de Donk, N. W. C. J., Avet-Loiseau, H., Hajek, R., Vangsted, Annette Juul, Ludwig, H., Zweegman, S., Moreau, P., Einsele, H., Boccadoro, M., San Miguel, J., Dimopoulos, M. A. & Sonneveld, P., 2020, In: Leukemia. 34, 8, p. 2000-2011 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

    Terpos, E., Musto, P., Engelhardt, M., Delforge, M., Cook, G., Gay, F., van de Donk, N. W. C. J., Ntanasis-Stathopoulos, I., Vangsted, A. J., Driessen, C., Schjesvold, F., Cerchione, C., Zweegman, S., Hajek, R., Moreau, P., Einsele, H., San-Miguel, J., Boccadoro, M., Dimopoulos, M. A., Sonneveld, P. & 1 others, Ludwig, H., 2023, In: Leukemia. 37, 6, p. 1175-1185 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

ID: 9762536